FDA To Decide On Expanded Use Of Gardasil In Older Women In Mid-June
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Merck anticipates receiving an FDA decision by mid-June on expanding use of its human papillomavirus Gardasil to women aged 27 through 45